Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

ClinicalTrials.gov ID: NCT00077779

Public ClinicalTrials.gov record NCT00077779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to test whether Adalimumab (at two different doses) can induce and maintain clinical remission in subjects with active Crohn's disease when compared to placebo (a substance containing no medication)

Study identification

NCT ID
NCT00077779
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
854 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2003 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Sep 26, 2007

Started 2003

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Thornton Hospital Reumatology Division La Jolla California 92037-0943 —
UCSF San Francisco General Hospital San Francisco California 94110 —
Cal-West, Inc. San Francisco California 94117 —
Western States Clinical Research Arvada Colorado 80002 —
Gastroenterology Associates of Fairfield County Bridgeport Connecticut 06606 —
Clinical Research of West Florida, Inc. Clearwater Florida 33765 —
V.A. Medical Center Gainsville Florida 32608 —
Mark Lamet, MD Hollywood Florida 33021 —
Gastroenterology Consultants Ormond Beach Florida 32174 —
Northwest Gastroenterology Arlington Heights Illinois 60005 —
Northwestern University Chicago Illinois 60611 —
The University of Chicago Chicago Illinois 60637 —
Indianapolis Gastroenterology Research Foundation Indianapolis Indiana 46237 —
St. Vincent Hospital: Research Department Indianapolis Indiana 46260 —
Drug Research Services, Inc. Metairie Louisiana 70001 —
Maryland Clinical Trials Annapolis Maryland 21401 —
Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Capital Gastroenterology Consultants, P.A. Silver Spring Maryland 20901 —
Clinical Pharmacology Study Group Worcester Massachusetts 01610 —
Mayo Clinic Research Rochester Minnesota 55905-0002 —
Gastroenterology & Hematology Kansas City Missouri 64131 —
Glenn Gordon, MD Mexico Missouri 65265 —
Washington University School of Medicine St Louis Missouri 63110 —
Washington University School St Louis Missouri 63110 —
Long Island Clinical Research Assoc. Great Neck New York 11021 —
NY Center for Clinical Research Lake Success New York 11042 —
Daniel Present, MD New York New York 10029 —
Digestive Disease Associates of Rockland Pomona New York 10970 —
Charlotte Gastroenterology & Hepatology Charlotte North Carolina 28207 —
Carolina Digestive Health Associates Charlotte North Carolina 28211 —
Carolina Research Associates Charlotte North Carolina 28262 —
Le Bauer Research, P.A. Greensboro North Carolina 27403 —
Wilmington Gastroenterology Wilmington North Carolina 28401 —
University Hospitals of Cleveland Cleveland Ohio 44106 —
Westhills Gastroenterology Portland Oregon 98112 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15261 —
Columbia Gastro Associates Columbia South Carolina 29204 —
Gastroenterology Center of the Mid South Memphis Tennessee 38120 —
Nashville Medical Research Nashville Tennessee 37205 —
Gastrointestinal Specialists Richmond Virginia 23230 —
Discovery Research Inteternational, LLC Milwaukee Wisconsin 53215 —
Wisconsin Center for Advanced Research Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00077779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2007 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00077779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →